Collectively, it is plausible to hypothesise that the only conditions in which foetal overgrowth is associated with quantitative changes in GLUT expression are maternal diabetes mellitus and obesity. The gene discussed is SLC2A1; the disease is obesity due to melanocortin 4 receptor deficiency.